Patents/Assignees

Cancer Research Technology Limited

35 patents in portfolio

US11787786utility2023
Fused 1,4-dihydrodioxin Derivatives as Inhibitors of Heat Shock Transcription Factor 1
0 cites
US11787792utility2023
5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 Pyridyl]amino]pyrazine-2-carbonitrile and Therapeutic Uses Thereof
0 cites
US11787866utility2023
Anti-cd25 Antibody Agents
0 cites
US11780929utility2023
Immunomodulatory Antibodies
0 cites
US11766434utility2023
Pyrimidinone Derivatives as CDC7 Inhibitors
0 cites
US11753405utility2023
1,3,4-thiadiazole Compounds and Their Use in Treating Cancer
0 cites
US11697688utility2023
Anti-cd25 for Tumour Specific Cell Depletion
0 cites
US11680068utility2023
Compounds Useful as RET Inhibitors
0 cites
US11661423utility2023
Heterocyclic Compounds as RET Kinase Inhibitors
0 cites
US11634773utility2023
Analysis of HLA Alleles in Tumours and the Uses Thereof
0 cites
US11603367utility2023
Isoindolinone Inhibitors of the MDM2-P53 Interaction and Process for Making Them
0 cites
US11566029utility2023
Pyrazolo[1,5-a]pyrimidine-5,7-diamine Compounds as CDK Inhibitors and Their Therapeutic Use
0 cites
US11560406utility2023
Anti-androgen Peptides and Uses Thereof in Cancer Therapy
0 cites
US11548896utility2023
Heterocyclic Compounds as RET Kinase Inhibitors
0 cites
US8343953utility2013
Pharmaceutical Compounds
0 cites

← PreviousPage 2 of 2